JUNS — JUPITER NEUROSCIENCES, INC.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1679628 ·
Last close
$2.67
Market Cap
$3.52M
52W High
$138.00
52W Low
$2.67
ADV30
1,845,607
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 24,245 | 21,064 | -2,742,945 | -2,274,397 | 3,718,600 | 1,521,874 | 4,084,566 |
| Mar 2026 | 18,652 | 14,290 | -1,963,000 | -2,061,958 | 3,948,584 | 2,362,749 | 6,732,041 |
| Dec 2025 | 21,796 | — | -2,808,785 | -2,575,031 | 5,564,030 | 3,789,342 | 7,395,882 |
| Sep 2025 | 0 | — | -2,297,053 | -2,288,034 | 2,576,259 | 723,797 | 2,518,842 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-5,782,795
Investing CF
—
Financing CF
$5,439,075
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-18.75
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-36,728,984
Inventory
$148,068
Receivables
$0
ST Investments
—
EBIT TTM
$-8,994,553
Pretax Income TTM
$-9,177,988
Interest Exp TTM
$183,435
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$64,693
EBITDA
—
Free Cash Flow
$-3,261,390
Enterprise Value
$2,575,949
Total Cash
$1,521,874
Total Debt
$1,749,076
Shares Out
1,318,521
Trailing EPS
$-18.70
Book Value
$-0.55
ROE
-1888.7%
ROA
-159.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 21,796 | -8,908,721 | -8,644,897 | 5,564,030 | 7,395,882 | -1,831,852 | -5,413,736 |
| Dec 2024 | 0 | -3,091,282 | -2,439,625 | 6,202,409 | 2,030,401 | 4,172,008 | -3,911,004 |
| Dec 2023 | 0 | -3,870,771 | -4,783,689 | 148,592 | 5,949,946 | -5,801,354 | -480,953 |
| Dec 2022 | 233,281 | -3,432,447 | -4,957,580 | 235,944 | 7,380,028 | -7,144,084 | -1,248,504 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.06
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| MBIO | MUSTANG BIO, INC. | $3.50M | $0.52 | — |
| HCWB | HCW Biologics Inc. | $3.54M | $1.93 | — |
| REVB | REVELATION BIOSCIENCES, INC. | $3.47M | $0.87 | — |
| APVO | Aptevo Therapeutics Inc. | $3.42M | $1.89 | — |
| PRFX | PRF Technologies Ltd. | $3.42M | $0.98 | — |
News headlines (Yahoo Finance, 1h cache)
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
2026-08-31 14:12 · Yahoo
Real Parkinson’s Disease Hope from Jupiter Neurosciences
2026-08-19 16:32 · Yahoo
Psychedelic Therapy Meets M&A: Fireside Chat with Jupiter Neurosciences CEO Christer Rosén & President Alison Silva
2026-07-22 17:25 · Yahoo
Jupiter Neurosciences Signs ALA-002 License Agreement Worth Up to $100 Million (NASDAQ:JUNS)
2026-07-21 14:27 · Yahoo
Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million
2026-07-21 11:13 · Yahoo
PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002
2026-07-21 11:00 · Yahoo
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
2026-05-26 16:00 · Yahoo
Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering
2026-05-20 18:38 · Yahoo
Jupiter Neurosciences Secures $100M Term Sheet for Exclusive U.S. Rights to ALA-002, a Next-Generation MDMA Therapeutic from PharmAla Biotech
2026-05-20 11:38 · Yahoo
Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit
2026-05-04 15:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.